153 related articles for article (PubMed ID: 17063489)
1. The interaction of adenovirus E1A with p300 family members modulates cellular gene expression to reduce tumorigenicity.
Miura TA; Cook JL; Potter TA; Ryan S; Routes JM
J Cell Biochem; 2007 Mar; 100(4):929-40. PubMed ID: 17063489
[TBL] [Abstract][Full Text] [Related]
2. Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development.
Routes JM; Ryan S; Li H; Steinke J; Cook JL
Virology; 2000 Nov; 277(1):48-57. PubMed ID: 11062035
[TBL] [Abstract][Full Text] [Related]
3. E1A oncogene expression level in sarcoma cells: an independent determinant of cytolytic susceptibility and tumor rejection.
Cook JL; Wilson BA; Wolf LA; Walker TA
Oncogene; 1993 Mar; 8(3):625-35. PubMed ID: 8437846
[TBL] [Abstract][Full Text] [Related]
4. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
Cook JL; Miura TA; Iklé DN; Lewis AM; Routes JM
Cancer Res; 2003 Jun; 63(12):3435-43. PubMed ID: 12810682
[TBL] [Abstract][Full Text] [Related]
5. Impact of the interaction between adenovirus E1A and CtBP on host cell gene expression.
Johansson C; Zhao H; Bajak E; Granberg F; Pettersson U; Svensson C
Virus Res; 2005 Oct; 113(1):51-63. PubMed ID: 15899534
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis.
Li X; Jung C; Liu YH; Bae KH; Zhang YP; Zhang HJ; Vanderputten D; Jeng MH; Gardner TA; Kao C
J Gene Med; 2006 Jun; 8(6):679-89. PubMed ID: 16570242
[TBL] [Abstract][Full Text] [Related]
7. The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300.
Avantaggiati ML; Carbone M; Graessmann A; Nakatani Y; Howard B; Levine AS
EMBO J; 1996 May; 15(9):2236-48. PubMed ID: 8641289
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
9. [Effect of E1A gene on in vitro growth inhibition and radiochemosensitivity of lymph node metastasis cells of human head and neck squamous cell carcinoma].
Wang XL; Qian XL; Zhao QZ; Xu ZG; Tang PZ
Ai Zheng; 2003 Nov; 22(11):1140-6. PubMed ID: 14613640
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus E1a-mediated tumor suppression by a c-erbB-2/neu-independent mechanism.
Frisch SM; Dolter KE
Cancer Res; 1995 Dec; 55(23):5551-5. PubMed ID: 7585633
[TBL] [Abstract][Full Text] [Related]
11. In vivo antitumor effect of retrovirus-mediated gene transfer of the adenovirus E1a gene.
Sánchez-Prieto R; Quintanilla M; Martín P; Lleonart M; Cano A; Dotto GP; Ramón y Cajal S
Cancer Gene Ther; 1998; 5(4):215-24. PubMed ID: 9694073
[TBL] [Abstract][Full Text] [Related]
12. Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cells.
Dickopp A; Esche H; Swart G; Seeber S; Kirch HC; Opalka B
Cancer Gene Ther; 2000 Jul; 7(7):1043-50. PubMed ID: 10917207
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding.
Routes JM; Li H; Bayley ST; Ryan S; Klemm DJ
J Immunol; 1996 Feb; 156(3):1055-61. PubMed ID: 8557979
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.
Routes JM; Ryan S; Morris K; Takaki R; Cerwenka A; Lanier LL
J Exp Med; 2005 Dec; 202(11):1477-82. PubMed ID: 16314433
[TBL] [Abstract][Full Text] [Related]
15. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus E1A orchestrates the urokinase-plasminogen activator system and upregulates PAI-2 expression, supporting a tumor suppressor effect.
Fernández-Soria V; Lleonart ME; Diaz-Fuertes M; Villuendas R; Sánchez-Prieto R; Fabra A; Ramón Y Cajal S
Int J Oncol; 2006 Jan; 28(1):143-8. PubMed ID: 16327990
[TBL] [Abstract][Full Text] [Related]
17. Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: repression of transcriptional activation by p53.
Kannabiran C; Morris GF; Mathews MB
Oncogene; 1999 Dec; 18(54):7825-33. PubMed ID: 10618724
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo.
Deng J; Xia W; Hung MC
Oncogene; 1998 Oct; 17(17):2167-75. PubMed ID: 9811448
[TBL] [Abstract][Full Text] [Related]
19. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M
Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882
[TBL] [Abstract][Full Text] [Related]
20. E1A physically interacts with RUNX3 and inhibits its transactivation activity.
Cha EJ; Oh BC; Wee HJ; Chi XZ; Goh YM; Lee KS; Ito Y; Bae SC
J Cell Biochem; 2008 Sep; 105(1):236-44. PubMed ID: 18570183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]